ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,262.71
-0.39%
Dow Jones
38,515.58
-0.14%
US Dollar vs MXN
17.77575
0.41%
Brent Oil
77.225
-1.17%
Bitcoin
70,152.90
1.96%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Horizon Therapeutics Public Limited Company (HZNP)

  7. Horizon Therapeutics Public Limited Company (HZNP) Noticias

HZNP

Horizon Therapeutics Pub... (HZNP)

Horizon Therapeutics Public Limited Company
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HZNP
FechaHoraFuenteTítuloSímboloCompañía
16/10/202315:44Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:HZNPHorizon Therapeutics Public Limited Company
09/10/202306:33IH Market NewsMonday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers, Disney, Lockheed Martin, and moreNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202317:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202315:30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202315:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202307:30Business WireRule 17(e) Announcement - Horizon Therapeutics plcNASDAQ:HZNPHorizon Therapeutics Public Limited Company
05/10/202306:40Business WireRule 17(d) Announcement – Horizon Therapeutics plcNASDAQ:HZNPHorizon Therapeutics Public Limited Company
03/10/202310:15Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
02/10/202307:00Business WireHorizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023NASDAQ:HZNPHorizon Therapeutics Public Limited Company
29/09/202309:00Business WireNew Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient OutcomesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
26/09/202308:02Business WireHorizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care IndustryNASDAQ:HZNPHorizon Therapeutics Public Limited Company
19/09/202307:00Business WireHorizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 ListNASDAQ:HZNPHorizon Therapeutics Public Limited Company
13/09/202307:00Business WireQ32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia AreataNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/09/202315:15Business WireHorizon Therapeutics plc (“Horizon”) Rule 2.12 AnnouncementNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/09/202306:20IH Market NewsWednesday’s Wall Street Highlights: Verb Technology, Apple, Alphabet, Warner Bros, and moreNASDAQ:HZNPHorizon Therapeutics Public Limited Company
05/09/202308:05Business WireHorizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of ArrangementNASDAQ:HZNPHorizon Therapeutics Public Limited Company
03/09/202315:24KR Market News주말 Biz 뉴스 요약: 노보 노디스크, ARM, 디즈니, 암젠NASDAQ:HZNPHorizon Therapeutics Public Limited Company
01/09/202317:07KR Market News암젠, FTC로부터 278억 달러 호라이즌 거래 승인 획득NASDAQ:HZNPHorizon Therapeutics Public Limited Company
01/09/202313:46Dow Jones NewsTrending: FTC Ends Challenge of Amgen/Horizon DealNASDAQ:HZNPHorizon Therapeutics Public Limited Company
01/09/202308:20PR Newswire (US)AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITIONNASDAQ:HZNPHorizon Therapeutics Public Limited Company
01/09/202308:20Business WireAmgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close AcquisitionNASDAQ:HZNPHorizon Therapeutics Public Limited Company
28/08/202316:13KR Market News인플레이션과 고용 데이터를 앞두고 美 증시 상승 마감NASDAQ:HZNPHorizon Therapeutics Public Limited Company
28/08/202308:06IH Market NewsMonday’s Wall Street Highlights: Jabil, Xpeng, 3M, Hostess Brands, and moreNASDAQ:HZNPHorizon Therapeutics Public Limited Company
26/08/202320:12KR Market News美 FTC, 암젠의 호라이즌에 대한 $278억 거래 차단 중지NASDAQ:HZNPHorizon Therapeutics Public Limited Company
23/08/202307:00Business WireHorizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy GroupsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
09/08/202309:30Business WireHorizon Therapeutics plc - Rule 2.12 AnnouncementNASDAQ:HZNPHorizon Therapeutics Public Limited Company
08/08/202307:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HZNPHorizon Therapeutics Public Limited Company
08/08/202306:00Business WireHorizon Therapeutics plc Reports Second-Quarter 2023 Financial ResultsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
03/08/202318:10KR Market News암젠의 분기별 매출 6% 증가, 이익은 추정치 상회NASDAQ:HZNPHorizon Therapeutics Public Limited Company
27/07/202307:00Business WireHorizon Therapeutics plc Announces 2023 #RAREis Global Advocate Grant RecipientsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
 Showing the most relevant articles for your search:NASDAQ:HZNP

Su Consulta Reciente

FX
USDMXN
US Dollar vs MXN
NYSE
MRK
Merck
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
CCOM
SILVER
SILVER
COIN
BTCUSD
Bitcoin
COIN
SOLUSD
Solana
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
NYSE
XOM
Exxon Mobil
NYSE
KO
Coca Cola
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
FX
EURUSD
Euro vs US Dollar
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados